OKYO - OKYO Pharma Ltd

QQQ $ 431.01 $ 6.55 (1.54 %)

DIA $ 382.27 $ 1.39 (0.36 %)

SPY $ 508.26 $ 4.77 (0.95 %)

TLT $ 88.26 $ 0.46 (0.52 %)

GLD $ 216.60 $ 0.70 (0.32 %)

Previous Close

$ 1.4701

Open

$ 1.40

Bid

$ 1.47 x 200

Ask

$ 1.54 x 300

Day's Range

$ 1.40 - $ 1.43

52 Week Range

$ 0.92 - $ 3.07

Volume

11,767

Average Volume

Market Cap

918,813

Beta (5Y Monthly)

$ 1.66

PE Ratio (TTM)

EPS (TTM)

TBD

Earnings Date

Dividend & Yield

na ($ 0.00)

Last Ex-Dividend

1y Target Est

TBD na

How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In

#	Filing Date	Period End Date	Type	Report Link
No Data found

Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In

#	Date	Analyst Firm	Upside/Downside	Price Target Change	Rating Change	Current Rating

News
OPINIONS

News

OPINIONS

why-landos-biopharma-shares-are-trading-higher-by-over-170-here-are-other-stocks-moving-in-mondays-mid-day-session

Why Landos Biopharma Shares Are Trading Hi...
03/25/2024 18:44:08

Shares of Landos Biopharma, Inc. (NASDAQ: LABP) rose sharply during Monday’s session following acquisition news.

why-salarius-pharmaceuticals-shares-are-trading-higher-by-around-31-here-are-20-stocks-moving-premarket

Why Salarius Pharmaceuticals Shares Are Tr...
03/25/2024 12:03:24

Shares of Salarius Pharmaceuticals, Inc. (NASDAQ: SLRX) rose sharply in today’s pre-market trading following fourth-quarter re...

relief-for-dry-eye-disease-okyo-pharmas-candidate-shows-durable-pain-relief-in-mid-stage-study

Relief For Dry Eye Disease? OKYO Pharma's ...
03/22/2024 15:53:13

Latest findings from OKYO Pharma's Phase 2 trial on OK-101 for dry eye disease. Significant reductions in ocular pain, impr...

HC Wainwright & Co. Maintains Buy on OKYO ...
03/22/2024 15:05:23

HC Wainwright & Co. analyst Yi Chen maintains OKYO Pharma (NASDAQ:OKYO) with a Buy and raises the price target from $6 t...

OKYO Pharma shares are trading higher afte...
03/22/2024 11:12:22

OKYO Pharma Says OK-101 Achieves Statistic...
03/22/2024 11:03:48

12-health-care-stocks-moving-in-fridays-after-market-session

12 Health Care Stocks Moving In Friday's A...
03/01/2024 21:32:44

12-health-care-stocks-moving-in-mondays-pre-market-session

12 Health Care Stocks Moving In Monday's P...
02/12/2024 13:05:59

12-health-care-stocks-moving-in-fridays-intraday-session

12 Health Care Stocks Moving In Friday's I...
02/09/2024 17:31:35

12-health-care-stocks-moving-in-fridays-pre-market-session

12 Health Care Stocks Moving In Friday's P...
02/09/2024 13:06:11

The FDA Has Cleared Okyo Pharma's OK-101 A...
02/09/2024 12:02:33

12-health-care-stocks-moving-in-mondays-after-market-session

12 Health Care Stocks Moving In Monday's A...
01/08/2024 21:31:09

HC Wainwright & Co. Maintains Buy on OKYO ...
01/08/2024 13:17:59

HC Wainwright & Co. analyst Yi Chen maintains OKYO Pharma (NASDAQ:OKYO) with a Buy and raises the price target from $4 t...

Okyo Pharma Reports Safety And Efficacy Re...
01/08/2024 12:43:13

HC Wainwright & Co. Reiterates Buy on OKYO...
12/05/2023 11:49:23

HC Wainwright & Co. analyst Yi Chen reiterates OKYO Pharma (NASDAQ:OKYO) with a Buy and maintains $4 price target.

OKYO Pharma Announces Last Patient Enrolle...
12/04/2023 12:08:29

In addition, data analysis plans for the trial have now been finalized and submitted to FDA for feedback, in anticipation of da...

HC Wainwright & Co. Initiates Coverage On ...
11/02/2023 11:07:53

HC Wainwright & Co. analyst Yi Chen initiates coverage on OKYO Pharma (NASDAQ:OKYO) with a Buy rating and announces Pric...

OKYO Pharma Announces $5.84M Cash Raise an...
10/31/2023 11:26:52

OKYO Pharma Reports Filing Of An Investiga...
10/09/2023 11:01:25

Study enrollment is planned to commence during Q1 2024 following IND allowance by the FDA.

12-health-care-stocks-moving-in-thursdays-after-market-session

12 Health Care Stocks Moving In Thursday's...
10/05/2023 21:32:13